Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome

Journal of Lipid Research

Volumn 37, Issue 6, 1996, Pages 1169-1180

  Salen, Gerald ^a   Shefer, S ^a   Batta, A K ^a   Tint, G S ^a   Xu, G ^a   Honda, A ^a   Irons, M ^a   Elias, E R ^a  

^a NONE

Author keywords

7 dehydrocholesterol; 7 dehydrocholesterol 7 reductase; 8 dehydrocholesterol; lathosterol 5 dehydrogenase

Indexed keywords

7 DEHYDROCHOLESTEROL; LATHOSTEROL;

CATALYSIS; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; ENZYME ACTIVITY; HUMAN; PRIORITY JOURNAL; REVIEW; SMITH LEMLI OPITZ SYNDROME; STEROIDOGENESIS;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; DEHYDROCHOLESTEROLS; FEMALE; FETAL DEATH; HETEROZYGOTE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; SMITH-LEMLI-OPITZ SYNDROME;

EID: 0029890957     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Smith, D. W., L. Lemli, and J. M. Opitz. 1964. A newly organized syndrome of multiple congenital anomalies. J. Pediatr. 64: 210-217.
2. Opitz, J. M., and F. de la Cruz. 1994. Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference. Am. J. Med. Genet. 50: 326-338.
3. Blair, H. R., and J. K. Martin. 1966. A syndrome characterized by mental retardation, short stature, craniofacial dysplasia, and genital anomalies occurring in siblings. J. Pediatr. 69: 457-459.
4. Deaton, J. G., and L. O. Mendoza. 1973. Smith-Lemli-Opitz syndrome in a 23-year-old man. Arch. Intern. Med. 132: 422-423.
5. Garcia, C. A., P. A. McGarry, M. Voirol, and C. Duncan. 1973. Neurological involvement in the Smith-Lemli-Opitz syndrome: clinical and neuropathological findings. Dev. Med. Child Neurol. 15: 48-55.
6. Johnson, V. P. 1975. Smith-Lemli-Opitz syndrome: review and report of two affected siblings. Z. Kinderheilk. 119: 221-234.
7. Fierro, M., A. J. Martinez, J. W. Harbison, and S. H. Hay. 1977. Smith-Lemli-Opitz syndrome: neuropathological and ophthalmological observations. Dev. Med. Child Neurol. 19: 57-62.
8. Lowry, R. B., and S-L. Yong. 1980. Borderline intelligence in the Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 5: 137-143.
9. Cherstovoy, E. D., G. I. Lazjuk, T. I. Ostrovskaya, I. A. Shved, G. I. Kravtzova, I. W. Lurie, and A. I. Gerasimovoch. 1984. The Smith-Lemli-Opitz syndrome. A detailed pathological study as a clue to aetiological heterogeneity. Virchows Arch. [Pathol. Anat.] 404: 413-425.
10. Lowry, R. B., J. R. Miller, and J. R. MacLean. 1986. Micrognathia, polydactyly, and cleft palate. J. Pediatr. 72: 959-961.
11. Curry, C. J. R., J. C. Carey, J. S. Holland, D. Chopra, R. Fineman, M. Golabi, S. Sherman, R. A. Pagaon, J. Allanson, S. Shullman, M. Barr, V. McGravey, C. Dabiri, N. Schmike, E. Ives, and B. D. Hall. 1987. Smith-Lemli-Opitz syndrome-Type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality. Am. J. Med. Genet. 26: 45-57.
12. Bialer, M. G., V. B. Penchezade, E. Kahn, R. Libes, G. Krigsman, and M. L. Lesser. 1987. Female external genitalia and Mullerian duct derivatives in a 46, XY infant with the Smith-Lemli-Opitz syndrome. Am. J. Genet. 27: 723-731.
13. Gorlin, R. J., M. M. Cohen, and L. S. Levin. 1990. Syndrome of the Head and Neck (3rd edition). Oxford University Press, New York, NY. 890-895.
14. McKeever, P. A., and I. D. Young. 1990. Smith-Lemli-Opitz syndrome II: a disorder of the fetal adrenals? J. Med. Genet. 27: 465-466.
15. Pober, B. 1990. Smith-Lemli-Opitz syndrome. In Birth Defects Encyclopedia. M. L. Buyse, editor. Blackwell Scientific Publications, Cambridge, MA. 1570-1572.
16. Opitz, J. M., V. B. Penchaszadeh, M. C. Holt, L. M. Spano, and V. L. Smith. 1994. Smith-Lemli-Opitz (RSH) syndrome bibliography: 1964-1993. Am. J. Genet. 50: 339-343.
17. Muenke, M., R. C. M. Hennekam, and R. I. Kelley. 1994. Holoprosencephaly as a manifestation in Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 55: A35.
18. Irons, M., E. R. Elias, G. Salen, G. S. Tint, and A. K. Batta. 1993. Defective cholesterol synthesis in Smith-Lemli-Opitz syndrome. Lancet. 341: 1414.
19. Tint, G. S., M. Irons, M. R. Elias, A. K. Batta, R. Frieden, T. S. Chen, and G. Salen. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330: 107-113.
20. 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes. J. Clin. Invest. 96: 1779-1785.
21. Salen, G., S. Shefer, A. K. Batta, and G. S. Tint. 1995. Biochemical abnormalities in the Smith-Lemli-Opitz syndrome. Int. Ped. 10: 33-36.
22. Kelley, R. I. 1995. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin. Chim. Acta. 236: 45-58.
23. McGaughran, J., D. Donnai, P. Clayton, and K. Mills. 1994. Diagnosis of Smith-Lemli-Opitz syndrome. Letter to the Editor. N. Engl. J. Med. 330: 685-1686.
24. Seedorf, U., M. Walter, and G. Assmann. 1994. Diagnosis of Smith-Lemli-Opitz syndrome. Letter to the Editor. N. Engl. J. Med. 330: 1686-1687.
25. Seedorf, U., M. Foker, R. Voss, K. Meyer, F. Kannenberg, D. Meschede, K. Ulrich, J. Horst, A. Benninghoven, and G. Assmann. 1995. Smith-Lemli-Opitz syndrome diagnosed by using time-of-flight secondary-ion mass spectrometry. Clin. Chem. 41: 548-552.
26. Batta, A. K., G. S. Tint, G. Salen, S. Shefer, M. Irons, and E. R. Elias. 1994. Identification of 7-dehydrocholesterol and related sterols in patients with Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 50: 334.
27. Honda, A., G. S. Tint, G. Salen, A. K. Batta, T. S. Chen, and S. Shefer. 1995. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J. Lipid Res. 36: 1595-1601.
28. Honda, A., G. S. Tint, A. K. Batta, R. I. Kelley, M. Honda, T. Chen, S. Shefer, and G. Salen. 1996. 7-Dehydrocholesterol concentrations are markedly increased in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. Am. J. Med. Genet. In press.
29. Opitz, J. M., E. Seemanova, and D. Beneskova. 1996. RSH ('Smith-Lemli-Opitz') syndrome as a common, paradigmatic metabolic malformation syndrome. Am. J. Med. Genet. In press.
30. The Metabolic Basis of Inherited Diseases. 1983. 5th ed. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, M. S. Brown, and J. L. Goldstein, editors. McGraw-Hill Book Co. New York. Chap. 87, pp 897; Chap. 12, pp 279, Chap. 7, pp 180.
31. Tint, G. S., G. Salen, A. K. Batta, S. Shefer, M. Irons, E. Elias, D. N. Abuelo, V. P. Johnson, M. Lambert, R. Lutz, C. Schanen, C. A. Morris, G. Hoganson, and R. Hughes-Benzie. 1995. Severity and outcome correlate with plasma sterol levels in type I and type II variants of the Smith-Lemli-Opitz syndrome. J. Pediatr. 127: 82-87.
32. Tint, G. S., M. Seller, R. Hughes-Benzie, A. K. Batta, S. Shefer, D. Genest, M. Irons, E. Elias, and G. Salen. 1995. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. J. Lipid Res. 36: 89-95.
33. Steinberg, D., and J. Avigan, Jr. 1960. Studies of cholesterol biosynthesis. II. The role of desmosterol in the biosynthesis of cholesterol. J. Biol. Chem. 235: 3127-3129.
34. Tint, G. S., and G. Salen. 1977. Evidence for the early reduction of the 24,25 double bond in the conversion of lanosterol to cholesterol in cerebrotendinous xanthomatosis. Metabolism. 26: 721-729.
35. Tint, G. S., and G. Salen. 1974. Transformation of 5α-cholestan-7-en-3b-ol to cholesterol and cholestanol in cerebrotendinous xanthomatosis. J Lipid Res. 15: 256-262.
36. 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis. J. Lipid Res. 23: 597-603.
37. Clayton, R. B. 1965. Biosynthesis of sterols, steroids, and terpenoids. 1. Biosynthesis of cholesterol and the fundamental steps in terpenoid biosynthesis. Q. Rev. Chem. Soc. 19: 168-200.
38. Myant, N. B. 1981. The Biology of Cholesterol and Related Steroids. William Heinemann Medical Books Ltd., London. 910 pp.
39. Kandutsch, A. A., and A. E. Russell. 1960. Preputial gland sterols. III. A metabolic pathway from lanosterol to cholesterol. J. Biol. Chem. 235: 2256-2261.
40. 7 bond of 7-dehydrocholesterol. J. Biol. Chem. 237: 358-362.
41. Batta, A. K., G. S. Tint, S. Shefer, D. Abuelo, and G. Salen. 1995. Identification of 8-dehydrocholesterol (cholesta5,8-dien-3β-ol) in patients with Smith-Lemli-Opitz syndrome. J. Lipid Res. 36: 705-713.
42. Batta, A. K., G. Salen, G. S. Tint, and S. Shefer. 1995. Identification of 19-nor-5,7,9(10)-cholestatrien-3β-ol in patients with Smith-Lemli-Opitz syndrome. J. Lipid Res. 36: 2413-2418.
43. Axelson, M. 1991. Occurrence of isomeric dehydrocholesterols in human plasma. J. Lipid Res. 32: 1441-1448.
44. Cormier-Daire, V., C. Wolf, M. LeMerrer, A. Nivelon, D. Bonneau, H. Journel, F. Fellmann, A. Munnich, and C. Roux. 1996. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. In press.
45. Jeanty, P., D. Delbake, L. Lemli, and H. Dorchy. 1977. Smith-Lemli-Opitz syndrome without failure to thrive. Acta Paediatr. Belg. 30: 175-178.
46. Irons, M., E. R. Elias, G. S. Tint, G. Salen, R. Frieden, T. M. Buie, and M. Ampola. 1994. Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in 4 patients and treatment in 1 patient. Am. J. Med. Genet. 50: 347-352.
47. Natowicz, M. R., and J. E. Evans. 1994. Abnormal bile acids in the Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 50: 364-367.
48. Abuelo, D., G. S. Tint, R. Kelly, A. K. Batta, S. Shefer, and G. Salen. 1995. Prenatal diagnosis of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid. Am. J. Med. Genet. 56: 281-285.
49. Rossiter, J. P., K. J. Hofman, and R. I. Kelley. 1995. Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors. Am. J. Med. Genet. 56: 272-275.
50. McGaughran, J. M., D. Donnai, P. Clayton, and K. Mills. 1994. Diagnosis of Smith-Lemli-Opitz syndrome. Am. J. Med. Genet. 56: 269-271.
51. Roux, C., and M. Aubry. 1966. Action tératogène chez le rat d'un inhibiteur de la synthèsie du cholesterol, Ie AY 9944. C. R. Soc. Biol. 160: 1353-1357.
52. Roux, C., R. Dupuis, C. Horvath, and J-N. Talbot. 1980. Teratogenic effect of an inhibitor of cholesterol synthesis (AY 9944) in rats: correlation with maternal cholesterolemia. J. Nutr. 110: 2310-2312.
53. Roux, C., C. Horvath, and R. Dupuis. 1979. Teratogenic action and embryo lethality of AY 9944: prevention by a hypercholesterolemia-provoking diet. Teratolgy. 19: 35-38.
54. Dvornik, D., M. Kraml, J. Dubic, M. Givner, and R. Gaudry. 1963. A novel mode of inhibition of cholesterol biosynthesis. J. Am. Chem. Soc. 85: 3309.
55. 7-sterol metabolism. Biochemistry. 5: 1060-1064.
56. 7-reductase, on serum and tissue lipids in the rat. J. Lipid Res. 9: 587-595.
57. Pill, J., F. H. Stegmeier, and K. Schmidt. 1990. Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis. Meth. Find. Exp. Clin. Pharmacol. 12: 167-174.
58. 7-reductase inhibitor: BM 15.766. Proc. Eur. Teratol. Soc.
59. Minsker, D. H., J. S. MacDonald, R. T. Robertson, and D. L. Bokelman. 1983. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Teratology. 28: 449-456.
60. Xu, G., G. Salen, S. Shefer, G. C. Ness, T. S. Chen, Z. Zhao, and G. S. Tint. 1995. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. J. Clin. Invest. 95: 76-81.
61. Xu, G., G. Salen, S. Shefer, G. C. Ness, T. C. Chen, Z. Zhao, L. Salen, and G. S. Tint. 1995. Treatment of the cholesterol biosynthetic defect as seen in the Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766. Gastroenterology. 109: 1301-1307.
62. Irons, M., E. R. Elias, M. J. Bull, C. L. Greene, V. P. Johnson, L. Keppen, C. Schanen, G. S. Tint, and G. Salen. 1996. Treatment of Smith-Lemli-Opitz syndrome (SLOS): results of a multicenter trial. Am. J. Med. Genet. In press.
63. Wallace, M., R. T. Zori, T. Alley, E. Whidden, B. A. Gray, and C. A. Williams. 1994. Smith-Lemli-Opitz syndrome in a female with a de novo, balanced translocation involving 7q32: probable disruption of an SLOS gene. Am. J. Med. Genet. 50: 368-374.
64. Alley, T. L., B. A. Gray, S-H. Lee, S. Scherer, L-C. Tsui, G. S. Tint, C. A. Williams, R. Zori, and M. R. Wallace. 1995. Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q32.1 in a Smith-Lemli-Opitz syndrome patient. Am. J. Hum. Genet. 56: 1411-1416.